Acepodia, Inc. (TPEX:6976)
18.35
-0.05 (-0.27%)
Apr 2, 2025, 2:58 PM CST
Acepodia Revenue
In the year 2024, Acepodia had annual revenue of 427.00K TWD, down -97.43%. Acepodia had revenue of 116.00K in the half year ending December 31, 2024.
Revenue
427.00K
Revenue Growth
-97.43%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 427.00K | -16.17M | -97.43% |
Dec 31, 2023 | 16.59M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Polaris Group | 107.00M |